Prof. Philip Patsalos
- Sun Sep 22 1:00 PM - 1:40 PM Imperial DAED Polytherapy and Concurrent Pathologies: The Role of Therapeutic Drug Monitoring
Philip Patsalos is a Consultant Clinical Pharmacologist, a Professor of Clinical Pharmacology and Head of Pharmacology and Therapeutics at University College London-Institute of Neurology, at the National Hospital for Neurology and Neurosurgery, Queen Square and at the Epilepsy Society, Chalfont St Peter, UK. Professor Patsalos’ clinical and research interests relate to the therapeutics of epilepsy and include: new drug treatments and strategies, new drug development (Phase II and III trials) and formulations, pharmacokinetic profiling and drug interactions. He has in excess of 200 publications (books, book chapters and peer reviewed papers) and has served on various International League Against Epilepsy committees (including the Commission on Therapeutic Strategies, the Sub-Commission on Polytherapy and Drug Interaction and the Sub-Commission on Therapeutic Drug Monitoring) and International Association of Therapeutic Drug Monitoring and Clinical Toxicology committees (including the Clinical Pharmacokinetics Committee and the Impact of Therapeutic Drug Monitoring on Pharmacoeconomics Committee). He is presently an Editorial Board member of numerous journals including Drugs, Epilepsy Research and Treatment, European Neurology Journal, Expert Opinion on Emerging Drugs, Expert Review of Clinical Pharmacology, and Therapeutic Drug Monitoring. He is also Associate Editor of Epilepsia and of the Journal of Epileptology.